BioSpace News Archive

Evaxion Biotech Expands Its EVX-03 DNA Vaccine Program Into Non-Small Cell Lung Cancer

Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies, today announced that it has selected EVX-03 as the product candidate within its DNA technology platform to target a new indication with planned regulatory filing in H2 2022.

June 23, 2022
·
5 min read
ABOzymes Completes Seed Financing Round to Fund Development of Technology to Enable Universal Organ Transplants and Blood Transfusions

ABOzymes Biomedical Inc., today announced it has completed a substantially upsized seed financing.

June 23, 2022
·
2 min read
Glioblastoma Multiforme Treatment Market Revenue Would Increase 2.8X Between 2022 And 2032, Reaching Roughly US$ 7 Bn By 2032.

Fact.MR – A Market Research and Competitive Intelligence Provider: The Glioblastoma Multiforme Treatment Market revenues were estimated at US$ 2.6 Bn in 2021 and is anticipated to grow at a CAGR of 10.1% from 2022-2032, according to a recently published Fact.MR report.

June 23, 2022
·
7 min read
Business

Neuromagen Pharma Announces the Appointment of Professor Gal Ifergane, Head of the Neurology Department at Soroka Medical Center, to its Scientific Advisory Board

Neuromagen Pharma Ltd., a company developing a new class of drugs for the treatment of degenerative and senescence-associated diseases, announced the establishment of a Scientific Advisory Board and the appointment of Prof. Gal Ifergane, Head of the Neurology Department at Soroka Medical Center as its first member.

June 23, 2022
·
2 min read
Drug Development

Q32 Bio Presents New Preclinical Data at the International Society of Nephrology Frontiers Meeting Demonstrating the Therapeutic Potential of ADX-097

Data show that C3d-mediated tissue targeting of factor H results in potent, durable and efficacious local complement blockade without systemic complement inhibition.

June 23, 2022
·
3 min read